- Other Post Graduate Training - Loyola University Chicago Stritch School of Medicine (2005-2007), Epidemiology
- Medical School - Lokmanya Tilak Municipal Medical College, India (1980-1984)
- Internship - Maimonides Medical Center (1996-1998), General Surgery
- Residency - State University of New York at Brooklyn (1997-2002), Radiation Oncology
Kevin Albuquerque, M.D.
- Ken Sharma Professorship in Radiation Oncology
- Radiation Oncology
- Gynecologic Cancers
- Cervical Cancer
Dr. Albuquerque received his medical degree and a Master of Surgery at Bombay University’s Lokmanya Tilak Municipal Medical College in India. He completed two residencies there and went on to become a senior resident and research fellow in surgical oncology at Tata Memorial Cancer Hospital in Bombay. From there, he became a fellow of the Royal College of Surgeons in the United Kingdom.
He then moved to the United States, where he completed a residency in radiation oncology at S.U.N.Y. University Hospital, and a rotation in brachytherapy at Memorial Sloan-Kettering and Beth Israel Hospital.
Before joining the faculty of UT Southwestern in 2012, Dr. Albuquerque was an Associate Professor in Radiation Oncology at Loyola University Medical Center, where he also served as the Clinical Director of the Department of Radiation Oncology and as the Director of Brachytherapy.
At UT Southwestern, Dr. Albuquerque is an active member of the faculty, serving as the Director of Quality Improvement/Quality Assurance. He is a member of the Protocol Review and Monitoring Committee (PRMC) for UT Southwestern.
Dr. Albuquerque is a member of the American Society of Clinical Oncology, the American Society of Therapeutic Radiology, the American College of Radiology, and the American Brachytherapy Society. In addition, he co-chairs the gynecological radiation oncology track of the American Society of Therapeutic Radiology’s Annual Meeting Scientific Committee and serves as a reviewer for the Practical Radiation Oncology Journal and the International Journal of Radiation Oncology, Biology, Physics. He is board certified in radiation oncology by the American Board of Radiology.
He was a named a Texas Monthly Super Doctor in 2018.
Meet Dr. Albuquerque
Kevin Albuquerque, M.D., has spent his career treating breast and gynecologic cancers – including cervical, uterine, vulva, and ovarian cancer.
As Chief of Gynecological Radiation Oncology Service, Dr. Albuquerque is one of the few radiation oncologists in North Texas offering specialized brachytherapy, a targeted radiation therapy that sends radiation directly to the tumor. He says it offers the best chance at preserving – or even improving – a cancer patient’s quality of life.
In quality-of-life assessments on breast cancer patients, Dr. Albuquerque found that patients who received breast brachytherapy felt better, had more energy, and had a better quality of life overall than patients who underwent traditional radiation therapy. He hopes to perform similar quality-of-life studies for different types of gynecologic cancer.
As the field of radiation oncology advances, Dr. Albuquerque says better technology is improving cancer treatments, resulting in better outcomes for patients.
At UT Southwestern, Dr. Albuquerque offers image-guided, high-dose rate brachytherapy to treat tumors in the gynecologic tract. A new technology at the intersection of imaging and the delivery of radiation, this method allows doctors to see more precisely where the radiation is going.
“Image-guided brachytherapy is changing the field of radiation oncology, making it safer and more effective,” he says.
Regardless of the type of radiation therapy he uses, Dr. Albuquerque’s ultimate goal is restoring health to his patients.
“Many patients beat cancer, and that helps them change their lives for the better. When they’re given a second chance, they improve all aspects of their lives,” he says.
Vulva Cancer in Decision Making in Radiation Oncology: Volume 2
Albuquerque, K., J. J. Lu, W. L. Brady (2011), New York, Springer
Gynecologic Cancers in Gynecologic Cancers (Part of the Medical Radiology book series)
Albuquerque, K., Leung, E, Mayr, N. (2016), Switzerland, Springer International Publishing
- Vulva Cancer in Decision Making in Radiation Oncology: Volume 2
Predicting severe hematologic toxicity from extended-field chemoradiation of para-aortic nodal metastases from cervical cancer.
Yan K, Ramirez E, Xie XJ, Gu X, Xi Y, Albuquerque K Practical radiation oncology 2017 Jul
Defining the Place of Adjuvant Chemotherapy and Radiation for High-Risk Endometrial Cancer From Recent Randomized Clinical Trials: Some Answers, More Questions.
Albuquerque K, Chino J, Klopp A, Kamrava M, Beriwal S International journal of radiation oncology, biology, physics 2018 Nov 102 3 473-477
Electronic Medical Record-Based Radiation Oncology Toxicity Recording Instrument Aids Benchmarking and Quality Improvement in the Clinic.
Albuquerque K, Rodgers K, Spangler A, Rahimi A, Willett D Journal of oncology practice 2018 Feb JOP2017025163
Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy.
Mohamad O, Diaz de Leon A, Schroeder S, Leiker A, Christie A, Zhang-Velten E, Trivedi L, Khan S, Desai NB, Laine A, Albuquerque K, Iyengar P, Arriaga Y, Courtney K, Gerber DE, Hammers H, Choy H, Timmerman R, Brugarolas J, Hannan R Oncoimmunology 2018 7 7 e1440168
Quality Improvements of Veterans Health Administration Radiation Oncology Services Through Partnership for Accreditation With the ACR.
Kapoor R, Moghanaki D, Rexrode S, Monzon B, Ray M, Hulick PR, Albuquerque K, Rosenthal SA, Palta JR, Hagan MP Journal of the American College of Radiology : JACR 2018 Aug
Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration.
Mayadev J, Elshaikh MA, Christie A, Nagel C, Kennedy V, Khan N, Lea J, Ghanem A, Miller D, Xie XJ, Folkert M, Albuquerque K American journal of clinical oncology 2018 Apr
Value of combined adjuvant chemotherapy and radiation on survival for stage III uterine cancer: is less radiation equal to more?
Wang CJ, Christie A, Folkert MR, Xie XJ, Albuquerque K Journal of gynecologic oncology 2018 Jul 29 4 e49
Intermeshing breast reconstruction and postmastectomy radiation.
Sieber DA, Vandevender DK, Albuquerque KV Expert review of anticancer therapy 2010 Aug 10 8 1273-83
Chromatin modifications and the DNA damage response to ionizing radiation.
Kumar R, Horikoshi N, Singh M, Gupta A, Misra HS, Albuquerque K, Hunt CR, Pandita TK Frontiers in oncology 2012 2 214
Effectiveness of virtual reality simulation software in radiotherapy treatment planning involving non-coplanar beams with partial breast irradiation as a model.
Glaser S, Warfel B, Price J, Sinacore J, Albuquerque K Technology in cancer research & treatment 2012 Oct 11 5 409-14
Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: A multi-institution study.
Elshaikh MA, Al-Wahab Z, Mahdi H, Albuquerque K, Mahan M, Kehoe SM, Ali-Fehmi R, Rose PG, Munkarah AR Gynecologic oncology 2014 Dec
Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment.
Manders DB, Morón A, McIntire D, Miller DS, Richardson DL, Kehoe SM, Albuquerque KV, Lea JS American journal of clinical oncology 2016 Jun
American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.
Mayadev J, Viswanathan A, Liu Y, Li CS, Albuquerque K, Damato AL, Beriwal S, Erickson B Brachytherapy 2017 Jan - Feb 16 1 22-43
Reduced toxicity with equivalent outcomes using three-dimensional volumetric (3DV) image-based versus nonvolumetric point-based (NV) brachytherapy in a cervical cancer population.
Thomas KM, Maquilan G, Stojadinovic S, Medin P, Folkert MR, Albuquerque K Brachytherapy 2017 Jun
Automated high-dose rate brachytherapy treatment planning for a single-channel vaginal cylinder applicator.
Zhou Y, Klages P, Tan J, Chi Y, Stojadinovic S, Yang M, Hrycushko B, Medin P, Pompos A, Jiang S, Albuquerque K, Jia X Physics in medicine and biology 2017 Feb
Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional Study.
Albuquerque K, Folkert M, Mayadev J, Christie A, Liotta MR, Nagel C, Sevak P, Harkenrider MM, Lea JS, Hanna RK, Small WC, Miller DS, Xie XJ, Potkul RK, Elshaikh MA American journal of clinical oncology 2017 Feb
Remote location interstitial brachytherapy with patient stabilization and subsequent transport to an outpatient center for treatment is safe and effective for the treatment of gynecologic malignancies.
Tumati V, Folkert MR, Lawson S, Wise E, Wolcott S, Richardson D, Carlson M, Kehoe S, Lea J, Abdulrahman R, Albuquerque K Brachytherapy 2016 Mar
Long-term Benefit of Tumor Volume-Directed Involved Field Radiation Therapy in the Management of Recurrent Ovarian Cancer.
Albuquerque K, Patel M, Liotta M, Harkenrider M, Guo R, Small W, Ronald P International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2016 Jan
Role of image guided radiation therapy in obese patients with gynecologic malignancies.
Bray TS, Kaczynski A, Albuquerque K, Cozzi F, Roeske JC Practical radiation oncology 2013 Oct-Dec 3 4 249-55
Childhood adversity increases vulnerability for behavioral symptoms and immune dysregulation in women with breast cancer
Janusek LW, Tell D, Albuquerque K, Mathews HL Brain, Behavior, and Immunity 2013 30 149-162
The prognostic value of lymph node cross-sectional cancer area in node-positive breast cancer: a comparison with N stage and lymph node ratio.
Li Y, Holmes E, Shah K, Albuquerque K, Szpaderska A, Ersahin C Pathology research international 2012 2012 161964
Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer.
Albuquerque K, Tell D, Lobo P, Millbrandt L, Mathews HL, Janusek LW BMC cancer 2012 12 251
Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT.
Albuquerque K, Giangreco D, Morrison C, Siddiqui M, Sinacore J, Potkul R, Roeske J International journal of radiation oncology, biology, physics 2011 Mar 79 4 1043-7
Implementation of electronic checklists in an oncology medical record: initial clinical experience.
Albuquerque KV, Miller AA, Roeske JC Journal of oncology practice / American Society of Clinical Oncology 2011 Jul 7 4 222-6
3D CT-based volumetric dose assessment of 2D plans using GEC-ESTRO guidelines for cervical cancer brachytherapy.
Gao M, Albuquerque K, Chi A, Rusu I Brachytherapy 2010 Jan-Mar 9 1 55-60
Technical aspects of the integration of three-dimensional treatment planning dose parameters (GEC-ESTRO Working Group) into pre-implant planning for LDR gynecological interstitial brachytherapy.
Chi A, Gao M, Nguyen NP, Albuquerque K Technology in cancer research & treatment 2009 Jun 8 3 181-6
Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer.
Witek-Janusek L, Albuquerque K, Chroniak KR, Chroniak C, Durazo-Arvizu R, Mathews HL Brain, behavior, and immunity 2008 Aug 22 6 969-81
Lung and cardiac tissue doses in left breast cancer patients treated with single-source breast brachytherapy compared to external beam tangent fields.
Garza R, Albuquerque K, Sethi A Brachytherapy 2006 Oct-Dec 5 4 235-8
Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer.
Albuquerque KV, Singla R, Potkul RK, Smith DM, Creech S, Lo S, Emami B Gynecologic oncology 2005 Mar 96 3 701-4
Synergistic anti-proliferative activity of interleukin 1 and tumor necrosis factor.
Ruggiero V, Baglioni C Journal of immunology (Baltimore, Md. : 1950) 1987 Feb 138 3 661-3
Short-term quality of life following partial breast irradiation with balloon brachytherapy- comparison with whole breast irradiation.
Albuquerque K, Janusek L, Mathews H, Millbrandt L, Gabram S The breast journal 2010 May-Jun 16 3 325-6
Para-aortic nodal metastases in cervical cancer: a blind spot in the International Federation of Gynecology and Obstetrics staging system: current diagnosis and management
Hwang L, Bailey A, Lea J, Albuquerque K Future Oncology 2015 11 2 309-322
- Predicting severe hematologic toxicity from extended-field chemoradiation of para-aortic nodal metastases from cervical cancer.
- SABR for gynecological cancers, in combination with immunotherapy
- Brachytherapy outcomes for gynecological cancers
- Bone marrow-sparing techniques for pelvic radiation
- Gynecologic Cancers
- Cervical Cancer
- Endometrial Cancer
- Ovarian Cancer
- Peritoneal Cancer
- Vaginal Cancer
- Vulvar Cancer
- Radiation Therapy for Breast Cancer
- Radiation Therapy for Cancer
- Radiation Therapy for Melanoma
- Uterine Cancer
- Radiation Therapy for Gynecologic Cancer
Q&A by Dr. Albuquerque
Showing 1 locations